Hennion & Walsh Asset Management, Inc. Oric Pharmaceuticals, Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.35 Billion
- Q2 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 149,726 shares of ORIC stock, worth $1.45 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
149,726
Previous 156,643
4.42%
Holding current value
$1.45 Million
Previous $986,000
54.06%
% of portfolio
0.06%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding ORIC
# of Institutions
143Shares Held
75.9MCall Options Held
11.3KPut Options Held
2.7K-
Viking Global Investors LP6.57MShares$63.6 Million0.12% of portfolio
-
Nextech Invest Ag5.29MShares$51.1 Million7.95% of portfolio
-
Nextech Invest, Ltd. Zurich, V85.29MShares$51.1 Million6.85% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$46.7 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY4MShares$38.7 Million0.05% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $383M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...